- Home
- RLAY vs TIXT Comparison
RLAY vs TIXT Comparison
Compare RLAY & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- TIXT
- Stock Information
- Founded
- RLAY 2015
- TIXT 2005
- Country
- RLAY United States
- TIXT Canada
- Employees
- RLAY N/A
- TIXT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- TIXT EDP Services
- Sector
- RLAY Health Care
- TIXT Technology
- Exchange
- RLAY Nasdaq
- TIXT Nasdaq
- Market Cap
- RLAY 1.1B
- TIXT 1.1B
- IPO Year
- RLAY 2020
- TIXT 2021
- Fundamental
- Price
- RLAY $5.11
- TIXT $3.63
- Analyst Decision
- RLAY Strong Buy
- TIXT Hold
- Analyst Count
- RLAY 9
- TIXT 9
- Target Price
- RLAY $20.88
- TIXT $5.78
- AVG Volume (30 Days)
- RLAY 1.3M
- TIXT 415.8K
- Earning Date
- RLAY 11-06-2024
- TIXT 11-08-2024
- Dividend Yield
- RLAY N/A
- TIXT N/A
- EPS Growth
- RLAY N/A
- TIXT N/A
- EPS
- RLAY N/A
- TIXT N/A
- Revenue
- RLAY $10,006,000.00
- TIXT $2,659,000,000.00
- Revenue This Year
- RLAY N/A
- TIXT N/A
- Revenue Next Year
- RLAY N/A
- TIXT $2.80
- P/E Ratio
- RLAY N/A
- TIXT $32.14
- Revenue Growth
- RLAY N/A
- TIXT 0.49
- 52 Week Low
- RLAY $5.03
- TIXT $2.83
- 52 Week High
- RLAY $12.14
- TIXT $11.51
- Technical
- Relative Strength Index (RSI)
- RLAY 28.59
- TIXT 44.82
- Support Level
- RLAY $5.96
- TIXT $3.71
- Resistance Level
- RLAY $6.39
- TIXT $4.60
- Average True Range (ATR)
- RLAY 0.36
- TIXT 0.28
- MACD
- RLAY -0.04
- TIXT -0.02
- Stochastic Oscillator
- RLAY 5.10
- TIXT 0.51
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.